Positive fraction of systematic biopsies predicts risk of relapse after radical prostatectomy

Urology

Volumn 52, Issue 6, 1998, Pages 1079-1084

  Presti Jr , Joseph C ^a,b   Shinohara, Katsuto ^a,b   Bacchetti, Peter ^a   Tigrani, Vida ^a   Bhargava, Vivek ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATECTOMY; RECURRENCE RISK; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; TRANSRECTAL ULTRASONOGRAPHY;

AGED; BIOPSY, NEEDLE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK; RISK ASSESSMENT; SURVIVAL RATE;

EID: 0032400830     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00373-2     Document Type: Article

References (19)

1. Partin A.W., Kattan M.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. JAMA. 277:1997;1445-1451.
2. Presti J.C. Jr, Hricak H., Narayan P.A., et al. Local staging of prostatic carcinoma comparison of transrectal sonography and endorectal MR imaging . Am J Radiol. 166:1996;103-108.
3. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Role of percent positive biopsies and endorectal coil MRI in predicting prognosis in intermediate-risk prostate cancer patients. Cancer J Sci Am. 2:1996;343-350.
4. Ackerman D.A., Barry J.M., Wicklund R.A., et al. Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy. J Urol. 150:1993;1845-1850.
5. Peller P.A., Young D.C., Marmaduke D.P., et al. Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens. Cancer. 75:1995;530-538.
6. Terris M.K., Haney D.J., Johnstone I.M., et al. Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies. Urology. 45:1995;75-80.
7. Dietrick D.D., McNeal J.E., Stamey T.A. Core cancer length in ultrasound-guided systematic biopsies a preoperative evaluation of prostate cancer volume . Urology. 45:1995;987-992.
8. Goto Y., Ohori M., Arakawa A., et al. Distinguishing clinically important from unimportant prostate cancers before treatment value of systematic biopsies . J Urol. 156:1996;1059-1063.
9. Cupp M.R., Bostwick D.G., Myers R.P., et al. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis. J Urol. 153:1995;1543-1548.
10. Weldon V.E., Tavel F.R., Neuwirth H., et al. Failure of focal prostate cancer on biopsy to predict focal prostate cancer the importance of prevalence . J Urol. 154:1995;1074-1077.
11. Borirakchanyavat S., Bhargava V., Shinohara K., et al. Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy. Urology. 50:1997;373-378.
12. Stamey T., McNeal J., Freiha F., et al. Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol. 139:1988;1235-1241.
13. Ravery V., Boccon-Gibod L.A., Dauge-Geffroy M.C., et al. Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy. Urology. 44:1994;371-376.
14. Huland H., Hammerer P., Henke R.P., et al. Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal examination, prostate specific antigen and the results of 6 systematic biopsies. J Urol. 155:1996;1344-1347.
15. D'Amico A.V., Whittington R., Malkowicz S.B., et al. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. J Urol. 154:1995;131-138.
16. Schroder F.H., Hermanek P., Denis L., et al. The TNM classification of prostate cancer. Prostate. 4:1992;129-138.
17. McNeal J.E. Cancer volume and site of origin of adenocarcinoma in the prostate relationship to local and distant spread . Hum Pathol. 23:1992;258-266.
18. Narayan P., Gajendran V., Taylor S.P., et al. The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer. Urology. 46:1995;205-212.
19. Bostwick D.G., Qian J., Bergstralh E., et al. Prediction of capsular perforation and seminal vesicle invasion in prostate cancer. J Urol. 155:1996;1361-1367.